Literature DB >> 21247618

Increase in the incidence of gestational trophoblastic disease in The Netherlands.

Charlotte Lybol1, Chris M G Thomas, Johan Bulten, Jos A A M van Dijck, Fred C G J Sweep, Leon F A G Massuger.   

Abstract

OBJECTIVE: The objective of this study is to determine the incidence and time trends of gestational trophoblastic disease (GTD) in The Netherlands using population-based data.
METHODS: Data on patients with a pathologically confirmed diagnosis of GTD from 1995 to 2008 were obtained from PALGA, a national archive containing all histopathology reports in The Netherlands. Data on number of deliveries were obtained from the Database of Statistics Netherlands.
RESULTS: During the study period, 4249 GTD patients were registered. Overall incidence rates of hydatidiform mole (HM), choriocarcinoma and placental site trophoblastic tumor (PSTT) were 1.34 per 1000 deliveries, 3.1 per 100,000 deliveries, and 1.0 per 100,000 deliveries, respectively. Incidence rates of HM increased from 1.02 per 1000 deliveries in 1995 to 1.56 per 1000 in 2001, an increase of 0.091 per year (95% CI 0.081-0.101). After 2001 incidence rates remained constant (increase per year -0.010, 95% CI -0.045-0.024). Maternal age and ethnicity are known to influence the risk of HM. Highest incidences were observed in women under 20 and over 40years of age. The proportion of deliveries accounted for by women over 40years of age increased from 1.5% to 2.9%, whereas women under 20 accounted for 1.5% of deliveries. The proportion of live births of Asian descent increased from 2.6% to 3.7%.
CONCLUSION: The incidence of GTD in The Netherlands increased significantly from 1995 to 2008. This can partially be explained by increased maternal age and increased proportion of live births of Asian descent. Part of the increase might result from improved diagnostic techniques. However, these factors do not seem to account for the total observed increase and part of the increase therefore remains unexplained.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21247618     DOI: 10.1016/j.ygyno.2011.01.002

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  The roles of surgery and EMA/CO chemotherapy regimen in primary refractory and non-refractory gestational trophoblastic neoplasia.

Authors:  Adnan Aydiner; Serkan Keskin; Sinan Berkman; Ergin Bengisu; Huseyin Ridvan Ilhan; Faruk Tas; Erkan Topuz
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-23       Impact factor: 4.553

2.  A Multicenter Retrospective Study of Epithelioid Trophoblastic Tumors to Identify the Outcomes, Prognostic Factors, and Therapeutic Strategies.

Authors:  Wu Liu; Jianwei Zhou; Jie Yang; Xiufeng Huang
Journal:  Front Oncol       Date:  2022-05-23       Impact factor: 5.738

3.  Gestational and Non-gestational Trophoblastic Disease. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 032/049, December 2015).

Authors:  C Tempfer; L-C Horn; S Ackermann; M W Beckmann; R Dittrich; J Einenkel; A Günthert; H Haase; J Kratzsch; M C Kreissl; S Polterauer; A D Ebert; K T M Schneider; H G Strauss; F Thiel
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-02       Impact factor: 2.915

4.  Ultrasound diagnosis of molar pregnancy.

Authors:  Jackie A Ross; Alina Unipan; Jackie Clarke; Catherine Magee; Jemma Johns
Journal:  Ultrasound       Date:  2018-03-02

5.  Fertility-sparing uterine lesion resection for young women with gestational trophoblastic neoplasias: single institution experience.

Authors:  Xiaoyu Wang; Junjun Yang; Jie Li; Jun Zhao; Tong Ren; Fengzhi Feng; Xirun Wan; Yang Xiang
Journal:  Oncotarget       Date:  2017-06-27

6.  Incidence of gestational trophoblastic disease in South Korea: a longitudinal, population-based study.

Authors:  Jin-Sung Yuk; Jong Chul Baek; Ji Eun Park; Hyen Chul Jo; Ji Kwon Park; In Ae Cho
Journal:  PeerJ       Date:  2019-02-20       Impact factor: 2.984

7.  Clinical features and management of trophoblastic epithelioid tumors: A systematic review.

Authors:  Florin Gorun; Larisa Tomescu; Andrei Motoc; Cosmin Citu; Ioan Sas; Denis Mihai Serban; Marius Forga; Ioana Mihaela Citu; Oana Maria Gorun
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

8.  Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience.

Authors:  Melisa Lelic; Zlatan Fatusic; Ermina Iljazovic; Suada Ramic; Sergije Markovic; Selma Alicelebic
Journal:  Med Arch       Date:  2017-08

9.  Choriocarcinoma with brain metastasis after term pregnancy: A case report.

Authors:  Liang Song; Qingli Li; Rutie Yin; Danqing Wang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

10.  Decreasing incidence of registered hydatidiform moles in Denmark 1999-2014.

Authors:  Helle Lund; Mogens Vyberg; Helle Højmark Eriksen; Anni Grove; Annette Østergaard Jensen; Lone Sunde
Journal:  Sci Rep       Date:  2020-10-12       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.